← Back to Search

Technology-Enhanced Care for Depression in Cancer Patients (SCOPE-C Trial)

N/A
Recruiting
Led By Jesse R. Fann
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years or older
Participants must be ambulatory for clinical care visits
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

SCOPE-C Trial Summary

This trial compares the effectiveness of technology-enhanced collaborative care management to usual collaborative care management in reducing depression symptoms in patients with cancer.

Who is the study for?
This trial is for adults with clinically significant depression (PHQ-9 score >=10) who are undergoing active cancer treatment and can use a smartphone, tablet, or computer. It's not for those with advanced cancer limiting life expectancy to less than 9 months or individuals needing immediate specialty mental health care.Check my eligibility
What is being tested?
The study compares technology-enhanced collaborative care management (t-CoCM) versus usual care in managing depression for cancer patients. t-CoCM integrates tech tools to help clinicians deliver behavioral treatments and monitor patient progress more effectively.See study design
What are the potential side effects?
Since the interventions involve non-medical treatments like interviews, focus groups, surveys, and media/technology usage rather than drugs or surgery, typical medical side effects are not expected; however, participants may experience discomfort from discussing personal issues.

SCOPE-C Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can walk to my clinic appointments.

SCOPE-C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to guideline-level depression treatment
Change in depression severity
Level of treatment engagement (collaboration & coordination of care)
+1 more
Secondary outcome measures
Care Managers experience using the new technology
Care manager (CM) satisfaction with Collaborative Care Management (CoCM) of depression
Change in Alcohol, Smoking, and Substance Use
+13 more

SCOPE-C Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (t-CoCM)Experimental Treatment3 Interventions
Patients use the t-CoCM digital app platform and clinic care managers use the t-CoCM web-based registry platform to support delivery of collaborative care. Patient's complete surveys at baseline, 3, 6 and 9 months. Some patients also participate in an interview or focus group about their user experience with the t-CoCM digital platform. Care managers also participate in interviews regarding their experience with CoCM and the newly developed web-based platform.
Group II: Arm II (u-CoCM)Active Control2 Interventions
Patients receive usual care and clinic care managers deliver usual CoCM. Patients complete surveys at baseline, 3, 6 and 9 months.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,739 Previous Clinical Trials
1,847,552 Total Patients Enrolled
83 Trials studying Depression
87,026 Patients Enrolled for Depression
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,924,157 Total Patients Enrolled
81 Trials studying Depression
65,717 Patients Enrolled for Depression
Jesse R. FannPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium

Media Library

Technology-enhanced Collaborative Care Management Clinical Trial Eligibility Overview. Trial Name: NCT05012124 — N/A
Depression Research Study Groups: Arm II (u-CoCM), Arm I (t-CoCM)
Depression Clinical Trial 2023: Technology-enhanced Collaborative Care Management Highlights & Side Effects. Trial Name: NCT05012124 — N/A
Technology-enhanced Collaborative Care Management 2023 Treatment Timeline for Medical Study. Trial Name: NCT05012124 — N/A
Depression Patient Testimony for trial: Trial Name: NCT05012124 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the aims of this investigation?

"The main outcome of this trial, determined over a period spanning Baseline to 9 months, is patient adherence to depression therapy guidelines. A few secondary objectives are also being evaluated, such as alterations in the Patient's Global Impression of Change (PGIC) and satisfaction with care scales; SCL-10 indicators for anxiety severity; and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Co-e 30 scores measuring fatigue, pain levels, nausea/vomiting symptoms among others."

Answered by AI

Are there any vacancies for participants of this experiment?

"Affirmative. According to the clinicaltrials.gov page, this medical trial is actively recruiting patients since it was initially posted on April 15th 2022 and its latest update was June 8th 2022. A total of 390 participants are required from 3 distinct locations."

Answered by AI

Could you provide the aggregate figure for individuals enrolled in this research project?

"Indeed, the information accessible on clinicaltrials.gov shows that recruitment for this research is still ongoing. The trial was introduced on April 15th 2022 and last updated June 8th 2022; it requires 390 patients from 3 distinct healthcare facilities to participate."

Answered by AI

Who else is applying?

What state do they live in?
Washington
What site did they apply to?
Fred Hutch/University of Washington Cancer Consortium
MultiCare Regional Cancer Center - Tacoma
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I am on two drugs to help with my depression, but I still feel constantly down and tired.. depression rules my life.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE
2022. "Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05012124.
~162 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top